Cargando…
Growth Hormone Upregulates Melanocyte-Inducing Transcription Factor Expression and Activity via JAK2-STAT5 and SRC Signaling in GH Receptor-Positive Human Melanoma
Growth hormone (GH) facilitates therapy resistance in the cancers of breast, colon, endometrium, and melanoma. The GH-stimulated pathways responsible for this resistance were identified as suppression of apoptosis, induction of epithelial-to-mesenchymal transition (EMT), and upregulated drug efflux...
Autores principales: | Basu, Reetobrata, Kulkarni, Prateek, Qian, Yanrong, Walsh, Christopher, Arora, Pranay, Davis, Emily, Duran-Ortiz, Silvana, Funk, Kevin, Ibarra, Diego, Kruse, Colin, Mathes, Samuel, McHugh, Todd, Brittain, Alison, Berryman, Darlene E., List, Edward O., Okada, Shigeru, Kopchick, John J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769493/ https://www.ncbi.nlm.nih.gov/pubmed/31547367 http://dx.doi.org/10.3390/cancers11091352 |
Ejemplares similares
-
MON-311 GH Action Upregulates ABC Transporters And EMT Markers In A Syngeneic Melanoma Mouse Model
por: Qian, Yanrong, et al.
Publicado: (2019) -
SUN-336 Autocrine / Paracrine Growth Hormone (GH) Drives Multimodal Therapy Resistance in Growth Hormone Receptor (GHR)-expressing Human Cancers
por: Basu, Reetobrata, et al.
Publicado: (2019) -
Mice with gene alterations in the GH and IGF family
por: Qian, Yanrong, et al.
Publicado: (2021) -
SAT-LB054 Growth Hormone Receptor (GHR) Antagonism Suppresses Hepatocellular Carcinoma Growth in a Syngeneic Mouse Model
por: Mathes, Samuel, et al.
Publicado: (2019) -
Growth hormone receptor gene disruption in mature‐adult mice improves male insulin sensitivity and extends female lifespan
por: Duran‐Ortiz, Silvana, et al.
Publicado: (2021)